AUSCANN GROUP HOLDINGS LTD - News & Media

Market Cap $17.62M Add to my watchlist

Healthcare

AusCann Group Holdings Limited is an Australia-based company focused on the development... AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Its products include Neuvis, CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways. MicroMAX is an encapsulation technology for use in the field of animal therapeutics. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.More

NATURAL MEDICINE LEADERS

ASX-listed wellness consumer discretionary player Calmer Co (ASX:CCO) has revealed its e-commerce sales hit more than $10K per day in March.

No News & Media currently available.

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $17.62M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

AC8 (ASX) Chart

Day chart unavailable

AUSCANN GROUP HOLDINGS LTD - News & Media

Top Stories